经尿道等离子双极汽化电切术治疗高危前列腺增生症  

Transurethral plasmakentic vaporization of prostate in the treatment of high-risk benign prostatic hyperplasia

作　　者：苟举民 伯晓宁 黄明亮 刘家辉 

机构地区：[1]404医院泌尿外科,山东威海264200

出　　处：《实用医药杂志》2011年第10期868-869,共2页Practical Journal of Medicine & Pharmacy

摘　　要：目的探讨经尿道前列腺等离子双极汽化电切术治疗高危前列腺增生症的安全性和有效性。方法回顾性分析经尿道前列腺等离子双极汽化电切术治疗高危前列腺增生症98例的临床资料。结果本组98例高危前列腺增生症患者安全度过围手术期,手术时间36~120 min,平均（76±20.6）min。切除前列腺组织18~76 g,平均（38.65±20.4）g;国际前列腺症状评分（IPSS）、生活质量评分（QOL）、最大尿流率（Qmax）、残余尿（RUV）与术前相比有显著性改善（P〈0.05）。结论经尿道等离子双极汽化电切术是治疗高危前列腺增生症的安全有效的方法。Objective To investigate the safety and efficacy of transurethral plasmakentic vaporization of prostate（TUPKVP） in the treatment of high-risk benign prostatic hyperplasia（BPH）.Methods The clinical data of 98 patients with high-risk BPH treated with TUPKVP were reviewed retrospectively.Results All the patients were safe at periopertion.The men operative time was（76±20.6） min（ranged from 36min to 120min）.The resected BPH tissue weighted（38.65±20.4） g（ranged from 18 to 76 g）.IPSS,QOL,QMAX and RUV improved significantly compared with that of pre-operation（P0.05）.Conclusion TUPKVP is an effective and safe therapy for high-risk BPH.

关 键 词：经尿道等离子双极汽化电切 前列腺增生症 高危患者 

分 类 号：R697.3[医药卫生—泌尿科学]